Workflow
奥马珠单抗(茁乐)
icon
Search documents
几百亿的大生意,盯上过敏人
Hu Xiu· 2025-05-10 02:05
Group 1 - Allergies have become the sixth most common chronic disease globally, affecting approximately one-third of the population [4][5] - In China, the prevalence of allergic rhinitis among adults increased from 11.1% in 2005 to 17.6% in 2011, adding around 100 million patients [8] - The market for allergy testing in China grew from 400 million yuan in 2017 to 830 million yuan in 2022, with a compound annual growth rate of 15% [17] Group 2 - The sales of dust mite removal devices in China increased from 627,000 units in 2015 to 6.665 million units in 2022, with the market size growing from 280 million yuan to 2.8 billion yuan [18] - The children's allergy market in China has an annual consumption scale exceeding 20 billion yuan, with the total market size surpassing 50 billion yuan [21] - The market for anti-allergy medications is also expanding, with specific products like the dust mite drops priced at 225 yuan per box and the only approved treatment for chronic urticaria costing over 1,000 yuan per injection [20]